The global market for surgical heart valve management products was worth nearly $1.8bn in 2020 and is expected to decline at a compound annual growth rate (CAGR) of 0.6% by 2025, leaving it valued at approximately $1.7bn, according to a new report by Informa’s Meddevicetracker, “Surgical Heart Valve Repair and Replacement Devices.”
The report focuses purely on products used in open surgery, and not transcatheter technologies used in surgeries such as transcatheter...